This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United States
The drug VOCABRIA contains one active pharmaceutical ingredient (API):
1
Cabotegravir
UNII 3L12PT535M - CABOTEGRAVIR SODIUM
|
Cabotegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
VOCABRIA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
VOCABRIA Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
VOCABRIA Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J05AJ04 | Cabotegravir | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AJ Integrase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02497204 |
Country: EE | Ravimiamet | Identifier(s): 1835940, 1835951, 1835962 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1201481001, 1201481003 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 104241, 528379 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60543082, 67129301 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9045, 9046 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049281013, 049281025, 049281037 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6250050F1024, 6250408A1028, 6250408A2024 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091692, 1091693, 1091694 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100441698, 100441706, 100441712 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67282001, W67283001, W67284001 |
Country: US | FDA, National Drug Code | Identifier(s): 49702-248 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.